- Home
- ENOV
ENOV
Enovis Corporation
as of 03-09-2026 1:40pm EST
$23.97
$0.52
-2.14%
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 1.6B | IPO Year: | 2008 |
| Target Price: | $48.75 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -20.75 | EPS Growth: | -38.98 |
| 52 Week Low/High: | $21.00 - $40.70 | Next Earning Date: | 06-01-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 6.49% | Revenue Growth (next year): | 5.56% |
| P/E Ratio: | -1.18 | Index: | N/A |
| Free Cash Flow: | 19.9M | FCF Growth: | N/A |
Stock Insider Trading Activity of Enovis Corporation (ENOV)
Engert Oliver
Buy
Chief Administrative Officer
ENOV Mar 4, 2026
Avg Cost/Share
$25.10
Shares
250
Total Value
$6,275.00
Owned After
44,890
SEC Form 4
Engert Oliver
Buy
Chief Administrative Officer
ENOV Mar 3, 2026
Avg Cost/Share
$24.77
Shares
1,000
Total Value
$24,770.00
Owned After
44,890
SEC Form 4
Engert Oliver
Buy
Chief Administrative Officer
ENOV Feb 27, 2026
Avg Cost/Share
$25.50
Shares
1,000
Total Value
$25,500.00
Owned After
44,890
SEC Form 4
PRYOR DANIEL A
Sell
Other
ENOV Dec 9, 2025
Avg Cost/Share
$27.21
Shares
1,665
Total Value
$45,297.99
Owned After
160,449
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Engert Oliver | ENOV | Chief Administrative Officer | Mar 4, 2026 | Buy | $25.10 | 250 | $6,275.00 | 44,890 | |
| Engert Oliver | ENOV | Chief Administrative Officer | Mar 3, 2026 | Buy | $24.77 | 1,000 | $24,770.00 | 44,890 | |
| Engert Oliver | ENOV | Chief Administrative Officer | Feb 27, 2026 | Buy | $25.50 | 1,000 | $25,500.00 | 44,890 | |
| PRYOR DANIEL A | ENOV | Other | Dec 9, 2025 | Sell | $27.21 | 1,665 | $45,297.99 | 160,449 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 26, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 26, 2026 · 100% conf.
AI Prediction BUY
1D
+2.17%
$25.97
5D
+4.34%
$26.52
20D
+5.42%
$26.80
Price: $25.42 Prob +5D: 100% AUC: 1.000
0001420800-26-000008
cfx-20260226false0001420800February 26, 202600014208002026-02-262026-02-26
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 26, 2026
Enovis Corporation (Exact name of registrant as specified in its charter)
Delaware001-3404554-1887631 (State or other jurisdiction(Commission(I.R.S. Employer of incorporation)File Number)Identification No.)
2711 Centerville Road, Suite 400 Wilmington, DE 19808 (Address of Principal Executive Offices) (Zip Code)
(302) 252-9160 (Registrant's telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.001 per shareENOVNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On February 26, 2026, the Company issued a press release reporting financial results for the year ended ended December 31, 2025. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into Item 2.02 of this report by reference. The Company has scheduled a conference call for 8:30 a.m. Eastern on February 26, 2026 to discuss its financial results.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Enovis Corporation press release dated February 26, 2026, reporting financial results for the year ended December 31, 2025.
104 Cover Page Interactive Data File - The cover page from this Current Report on Form 8-K is formatted in Inline XBRL
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:February 26, 2026 Enovis Corporation
By:/s/ John Kleckner Name: John Kleckner Title:Vice President Controller and Chief Accounting Officer (Principal Accounting Officer)
2025 Q3 Q3 2025 Earnings
8-K Nov 6, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 6, 2025
0001420800-25-000038
cfx-20251106false00014208002025-11-06November 6, 202500014208002025-11-062025-11-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2025
Enovis Corporation (Exact name of registrant as specified in its charter)
Delaware001-3404554-1887631 (State or other jurisdiction(Commission(I.R.S. Employer of incorporation)File Number)Identification No.)
2711 Centerville Road, Suite 400 Wilmington, DE 19808 (Address of Principal Executive Offices) (Zip Code)
(302) 252-9160 (Registrant's telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.001 per shareENOVNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On November 6, 2025, the Company issued a press release reporting financial results for the third quarter ended October 3, 2025. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into Item 2.02 of this report by reference. The Company has scheduled a conference call for 8:30 a.m. Eastern on November 6, 2025 to discuss its financial results.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Enovis Corporation press release dated November 6 2025, reporting financial results for the third quarter ended October 3, 2025.
104 Cover Page Interactive Data File - The cover page from this Current Report on Form 8-K is formatted in Inline XBRL
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:November 6, 2025 Enovis Corporation
By:/s/ John Kleckner Name: John Kleckner Title:Vice President Controller and Chief Accounting Officer (Principal Accounting Officer)
2025 Q2 Q2 2025 Earnings
8-K Aug 7, 2025
2025
Q2
Q2 2025 Earnings
8-KAug 7, 2025
0001420800-25-000029
cfx-20250807false00014208002025-08-07August 7, 202500014208002025-08-072025-08-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 7, 2025
Enovis Corporation (Exact name of registrant as specified in its charter)
Delaware001-3404554-1887631 (State or other jurisdiction(Commission(I.R.S. Employer of incorporation)File Number)Identification No.)
2711 Centerville Road, Suite 400 Wilmington, DE 19808 (Address of Principal Executive Offices) (Zip Code)
(302) 252-9160 (Registrant's telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.001 per shareENOVNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On August 7, 2025, the Company issued a press release reporting financial results for the second quarter ended July 4, 2025. A copy of the Company's press release is attached to this report as Exhibit 99.1 and is incorporated into Item 2.02 of this report by reference. The Company has scheduled a conference call for 8:30 a.m. Eastern on August 7, 2025 to discuss its financial results.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Enovis Corporation press release dated August 7, 2025, reporting financial results for the second quarter ended July 4, 2025.
104 Cover Page Interactive Data File - The cover page from this Current Report on Form 8-K is formatted in Inline XBRL
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:August 7, 2025 Enovis Corporation
By:/s/ John Kleckner Name: John Kleckner Title:Vice President Controller and Chief Accounting Officer (Principal Accounting Officer)
Latest Enovis Corporation News
ENOV Breaking Stock News: Dive into ENOV Ticker-Specific Updates for Smart Investing
Compare ENOV vs Leading Stocks
See how ENOV stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ENOV Enovis Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.